Oxford University has initiated the first human trial of a Bundibugyo ebolavirus vaccine, testing its safety and immune response in 50 healthy adults aged 18 to 55.
The early-stage trial will involve 50 participants
Jul 13, 2026
07:47 pm
What's the storyThe University of Oxford has begun the first-ever human trial for a vaccine against Bundibugyo ebolavirus.
The move is part of an effort to curb an outbreak in the Democratic Republic of Congo and Uganda.
Oxford begins first human trial of vaccine targeting Bundibugyo Ebola strain
Scientists in Oxford will start to test the world's first vaccine against Bundibugyo Ebola, as an outbreak of the rare virus…
The jab could be ready to send to the Democratic Republic of Congo within weeks
Oxford's Ebola vaccine candidate has entered Phase 1 clinical trials for safety evaluation. The ChAdOx1 BDBV vaccine uses a…
Stay up to date with notifications from The IndependentNotifications can be managed in browser…
Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically…
Oxford University begins human trials of new Ebola vaccine
